Latest filing published 27 Oct 2022 for Hansa Biopharma AB, €9,779.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Markus Hökerberg: trading record in brief
Markus Hökerberg discloses dealings in Hansa Biopharma AB to Finansinspektionen. In total, 3 filings cover trades dated from 13 May 2022 to 26 October 2022.
The open-market record is one-sided, with 3 purchases worth €24k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €7,276. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 27 October 2022: an open-market purchase of €9,779, in Hansa Biopharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Markus Hökerberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,600 shares@ NOK 8.7140.7% of flowAktieISIN SE0014731154FI:csv-0155c3fef357942884b0Canonical exit: 24 Jan 2023 (T+90)
- 7,000 shares@ NOK 9.8029.0% of flowAktieISIN SE0014731154FI:csv-22ee2b8e4c7ce03322b6Canonical exit: 9 Nov 2022 (T+90)
- 9,562 shares@ NOK 7.8030.3% of flowAktieISIN SE0014731154FI:csv-0da9f570981bb0249c97Canonical exit: 11 Aug 2022 (T+90)
3 of 3 declarations